Edmond DE Rothschild Holding S.A. Increases Stake in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Edmond DE Rothschild Holding S.A. increased its stake in DENTSPLY SIRONA Inc. by 26.4% during Q1, owning approximately 1.46% of the company valued at $43.5 million at the end of the quarter.
• Several analysts recently downgraded DENTSPLY SIRONA's stock ratings, with a consensus target price of $18.64 and a predominant rating of "Hold" from eleven analysts.
• In addition to boosting its stake, DENTSPLY SIRONA declared a quarterly dividend of $0.16, providing an annual yield of 4.6%, with the dividend to be paid on October 10th.

Edmond DE Rothschild Holding S.A. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 26.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,913,400 shares of the medical instruments supplier's stock after acquiring an additional 609,300 shares during the period. Edmond DE Rothschild Holding S.A. owned about 1.46% of DENTSPLY SIRONA worth $43,526,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. raised its holdings in DENTSPLY SIRONA by 9.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier's stock valued at $7,391,000 after acquiring an additional 40,936 shares in the last quarter. Brown Advisory Inc. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $679,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of DENTSPLY SIRONA by 39.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock valued at $805,000 after purchasing an additional 15,117 shares during the period. GAMMA Investing LLC grew its stake in shares of DENTSPLY SIRONA by 1,462.9% in the 1st quarter. GAMMA Investing LLC now owns 99,351 shares of the medical instruments supplier's stock valued at $1,484,000 after purchasing an additional 92,994 shares during the period. Finally, Gotham Asset Management LLC grew its stake in shares of DENTSPLY SIRONA by 8.5% in the 4th quarter. Gotham Asset Management LLC now owns 770,809 shares of the medical instruments supplier's stock valued at $14,630,000 after purchasing an additional 60,111 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on XRAY shares. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, August 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a report on Friday, August 8th. Finally, UBS Group reduced their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Trading Down 1.0%

XRAY traded down $0.14 during trading on Tuesday, reaching $14.08. 1,729,765 shares of the stock traded hands, compared to its average volume of 2,977,148. The stock's 50-day moving average is $14.96 and its 200 day moving average is $15.13. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.48. The stock has a market capitalization of $2.81 billion, a PE ratio of -2.97, a P/E/G ratio of 0.91 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm's revenue was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.